BMRN
BioMarin Pharmaceutical Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $3.7B | +11.6% |
| Gross profit | $2.8B | +13.4% |
| Operating income | $114M | — |
| Net income | −$19M | −16.4% |
| EPS | −$0.08 | −16.7% |
| Free cash flow | $558M | — |
BioMarin Pharmaceutical Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $3.7B | +11.6% |
| Gross profit | $2.8B | +13.4% |
| Operating income | $114M | — |
| Net income | −$19M | −16.4% |
| EPS | −$0.08 | −16.7% |
| Free cash flow | $558M | — |